The Effect of Methods Used in Oral Antipyretic Administration on the Vital Findings of the Child With Fever

NCT05366049 | Completed

• 1 other identifier: E-59491012-604.01.02-2973
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Fever, one of the most common clinical journeys of childhood, makes up a fraction of emergency room admissions. About us-30. High fever, which is one of the first schools in infancy and childhood, can cause health problems such as not applying or starting the intervention. The most preferred method in the fire; antipyretic drug treatment in the hospital is routine . Antipyretics play a role in control plans and estimations of facts for cars of cars, the importance of word of mouth has some problems. In children, hospital, health care, injectors are grown from the breeder after completion, they can be created by red supplementation from the effects such as rearing without completion . resistance children; aspiration is risky, wrong dose is administered. It is stated in relation to teachers and verbal medicines for health. Hansen et al. Working with 61 babies aged 0-24 months, using a pacifier injector and a normal injector, children and temperature monitors. They are from the nipple injector used by mothers and women. There is a need for a new modification in the existing oral drug applications that will be able to support the adaptation and readiness of the child and to be able to effectively administer the drug. This work; Two different methods used to give antipyretic (medication pacifier and colored injector) were planned to be performed as pain, fever and purpose of life (respiratory rate, planning CTA) for the child.

Conditions

Fever; Heart Rate; Respiratory Rate; Pain

Keywords

children, oral medicine, medicine pacifier, injector, antipyretics

Outcome Measures

Primary Outcomes (1)

• Vital parameters

  Heart rate/minute

  before oral medications

Secondary Outcomes (1)

• Pain score

  before oral medications

Other Outcomes (18)

• vital parameters

  before oral medications

• vital parameters

  before oral medications

• Vital parameters

  after medications 15 minute

Study Arms (2)

using a medicine pacifier to give acetaminophen

EXPERIMENTAL

Other: using a medicine pacifier to give acetaminophen

using an enjector to give acetaminophen

ACTIVE COMPARATOR

Other: using a medicine pacifier to give acetaminophen

Interventions

using a medicine pacifier to give acetaminophen OTHER

While giving acetaminophen, the effect on the amount of taking the drug, pain and vital parameters are observed by using the drug pacifier.

using a medicine pacifier to give acetaminophen; using an enjector to give acetaminophen

Eligibility Criteria

• Age: Up to 24 Months
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)

You may qualify if:

• Applying to the pediatric emergency department with a complaint of high fever (38ºC).
• Being prescribed an antipyretic (paracetamol) by a physician.
• Those whose parents are literate and agree to participate in the study.
• Patients with triage color classification Yellow and Green.
• Children between 0-24 months will be included in the study.

You may not qualify if:

• Having used antipyretics in the last 6 hours.
• Being prescribed an antipyretic other than paracetamol by the physician.
• Having trouble in sucking-swallowing coordination.
• Children with chronic disease and neuromotor developmental delay.

Sponsors & Collaborators

• Istanbul University - Cerrahpasa: lead

Study Sites (1)

Istanbul Unisversity- Cerrahpasa

Istanbul, Fatih, 34320, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Fever; Pain

Condition Hierarchy (Ancestors)

Body Temperature Changes; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Neurologic Manifestations

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
• Masking Details: single blind
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: randomized controlled trial

Study Record Dates

• First Submitted: April 2, 2022
• First Posted: May 9, 2022
• Study Start: November 1, 2020
• Primary Completion: December 30, 2021
• Study Completion: August 30, 2022
• Last Updated: December 22, 2022

Record last verified: 2022-12

Locations

TU (1)